|

Navigating the Diagnosis of Mesothelioma: Insights from Expert Guidelines

ByHolly Zink
Navigating the Diagnosis of Mesothelioma: Insights from Expert Guidelines

Mesothelioma is a rare and hard-to-diagnose tumor. It poses challenges for patients and caregivers. However, the International Mesothelioma Interest Group recently released an update on expert guidelines.

It provides insights into mesothelioma’s diagnosis. These insights are valuable. They offer guidance for those facing this tough journey.

Understanding Mesothelioma

Mesothelioma mainly affects the pleura (85-90%) and peritoneum (10-15%). It is rare in the heart lining and near the testicles. Asbestos exposure is a significant risk but a diagnosis should not rely only on exposure history. A full assessment with clinical, radiographic, and pathological tests is key.

The new guidelines stress the need for examining the cell structure. They stress the need for specific proteins and genetic studies in diagnosing mesothelioma. These methods help pathologists tell apart different mesothelial tumors. They also help them identify mesothelioma from non-cancerous or other cancers.

Mesothelioma comes in three main subtypes: epithelioid, biphasic, and sarcomatoid. Knowing these types is key for a correct diagnosis and treatment plan. The guidelines also point out common mistakes in cell structure assessment. They highlight the need for pathologists to be skilled and thorough in their examination.

Patient-Centered Approaches

Immunohistochemistry confirms mesothelioma and separates it from other cancers. Additionally, tests like FISH help in complex cases. Correct diagnosis is crucial for treatment and legal reasons. When unsure, patients and caregivers should ask for thorough evaluations and second opinions.

Understanding the diagnostic process is empowering for those with mesothelioma. Following guidelines and talking to healthcare providers ensures a thorough diagnosis.

Dealing with mesothelioma diagnosis involves teamwork. Staying informed and seeking expert advice is key. This active approach can lead to better outcomes and a higher quality of life.

Source:

Husain, Aliya N., David B. Chapel, Richard Attanoos, Mary Beth Beasley, Luka Brcic, Kelly Butnor, Lucian R. Chirieac, et al. “Guidelines for Pathologic Diagnosis of Mesothelioma: 2023 Update of the Consensus Statement From the International Mesothelioma Interest Group.” Archives of Pathology & Laboratory Medicine, April 8, 2024. https://doi.org/10.5858/arpa.2023-0304-RA.

 

Similar Posts

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    ByAlex Strauss

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    ByAlex Strauss

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • | | |

    Mesothelioma Nurses Ready for New Cases in Australia

    ByAlex Strauss

    Australia is bracing for an expected new wave of mesothelioma cases in the next decade and the Lung Foundation of Australia is taking action now to get ready. The Foundation has paid for ten nurses from around the country to receive specialized training in helping patients and families cope with mesothelioma. The nurses, who have recently completed the training, are now equipped to lead treatment planning for these complex cancer patients and to help other nurses do the same. Pleural mesothelioma is an aggressive cancer that occurs in the lining around the lungs. It is caused by exposure to asbestos dust, a toxin that was once alarmingly prevalent in Australia where it was mined and heavily used in construction. Because…

  • | |

    Spanish Mesothelioma Deaths Likely to Continue for Decades

    ByAlex Strauss

    New research in Spain suggests that mesothelioma deaths will continue in the country until the “last surviving member” of the group of people exposed to occupational asbestos succumbs to the disease. Like many countries, Spain used asbestos heavily in the first half of the 20th century, especially in construction, where the mineral was prized for its durability, low cost, and resistance to fire and corrosion.  Asbestos was banned in Spain in 2002. Observing that more than 2.5 million metric tons of asbestos were imported into Spain from 1906 to 2002, researchers say deaths from mesothelioma have risen steadily. Between 1976 and 1980, a total of 491 Spanish people died of mesothelioma. By the 5-year period from 2006 to 2010, that…

  • | | |

    Human Trials Planned for Promising New Mesothelioma Drug

    ByAlex Strauss

    The Australian Asbestos Diseases Research Institute says it is ready to begin human trials on what its lead researcher calls the first significant advance in mesothelioma treatment in a decade. More than three years in development, TargomiRs utilizes a unique ‘minicell’ delivery system to insert a synthetic form of missing genetic material into mesothelioma cells. Like a number of other types of cancer, mesothelioma cells are missing a family of microRNAs critical to regulating the cellular life cycle. TargomiRs restores these microRNAs. In mice with human-derived mesothelioma, TargomiRs produced a “remarkable inhibition of tumour growth”, according to the Asbestos Diseases Research Institute. “The last significant development in the treatment of mesothelioma occurred ten years ago,” ADRI director Nico van Zandwijk…

  • | | |

    New Mesothelioma Treatment Targets Growth Factors

    ByAlex Strauss

    On the brink of a predicted “third wave” of mesothelioma cases in Australia, Australian scientists are testing a new kind of treatment that combines drugs and gene therapy. Australia has long had one of the highest per capita rates of mesothelioma, the most deadly of asbestos-linked diseases. Historically, mesothelioma cases occurred first among people who worked with asbestos in Australia’s mines. Later, new cases developed among people in industrial jobs like construction or shipbuilding. But, in recent years, there is growing concern about a third wave of mesothelioma cases among renovators, do-it-yourself homeowners and others with relatively low levels of exposure. In anticipation of this problem, scientists at Flinders University are working on a mesothelioma treatment that targets “key growth factors…